The Clinical practice guidelines for HCC surveillance for people at high risk in Australia aim to provide information and recommendations to guide surveillance for people at high risk of HCC. Evidence has shown it to be successful in detecting lesions and/or early-stage tumours, increasing the receipt of curative treatment and improving overall survival.

The development of these Guidelines was led by eminent clinicians in the area of liver disease and liver cancer, Co-Chairs Professor Jacob George and Dr Nicole Allard, alongside a multi-disciplinary working party, including healthcare and clinical representatives, representatives with lived experience and other community representatives. 

Read the Guidelines

---

Page updated 29 September 2023